Banks Surge On Results… And CPI’s Impact On The Fed 1/15/25
CNBC's "Fast Money"
00:00
Eli Lilly's Stock Dynamics and the Pharmaceutical Landscape
This chapter explores the recent decline in Eli Lilly's stock, driven by a disappointing outlook for its GLP-1 drugs. It examines investor hesitation, competitive pressures in the pharmaceutical market, and the implications of changing market dynamics.
Transcript
Play full episode
